![](/images/graphics-bg.png)
Safety Profile of Liver FibroScan in Patients with Cardiac Pacemakers or Implantable Cardioverter-Defibrillators
المؤلفون المشاركون
Worobetz, Lawrence
Chan, Yin
Pranke, Stephanie
Rashidi, Farid
Nosib, Shravan
المصدر
Canadian Journal of Gastroenterology and Hepatology
العدد
المجلد 2017، العدد 2017 (31 ديسمبر/كانون الأول 2017)، ص ص. 1-6، 6ص.
الناشر
Hindawi Publishing Corporation
تاريخ النشر
2017-02-27
دولة النشر
مصر
عدد الصفحات
6
التخصصات الرئيسية
الملخص EN
Background.
Emerging evidence suggests that nonalcoholic fatty liver disease (NAFLD) is associated with coronary artery diseases and arrhythmias.
The FibroScan (Echosens, France), a widely available, noninvasive device, is able to detect liver fibrosis and steatosis within this patient population.
However, the FibroScan is currently contraindicated in patients with cardiac pacemakers (PM) or implantable cardioverter-defibrillators (ICD).
Objective.
To determine the safety profile of FibroScan testing in patients with PM or ICD.
Methods.
Consecutive outpatients undergoing routine device interrogations at a tertiary level teaching hospital underwent simultaneous liver stiffness measurements.
PM or ICD performance data, device types, patient demographics, medical history, and previous laboratory and conventional liver imaging results were collected.
Results.
Analysis of 107 subjects with 33 different types of implanted cardiac devices, from 5 different companies (Medtronic, Sorin, ELA Medical, Boston Scientific, and St.
Jude), did not demonstrate any adverse events as defined by abnormal device sensing/pacing or ICD firing.
This population included high risk subjects undergoing active pacing (n=53) and with right pectoral PM placement (n=1).
None of the subjects had any clinical signs of decompensated congestive heart failure or cirrhosis during the exam.
Conclusion.
TE with FibroScan can be safely performed in patients with PM or ICD.
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
Chan, Yin& Pranke, Stephanie& Rashidi, Farid& Nosib, Shravan& Worobetz, Lawrence. 2017. Safety Profile of Liver FibroScan in Patients with Cardiac Pacemakers or Implantable Cardioverter-Defibrillators. Canadian Journal of Gastroenterology and Hepatology،Vol. 2017, no. 2017, pp.1-6.
https://search.emarefa.net/detail/BIM-1141461
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
Chan, Yin…[et al.]. Safety Profile of Liver FibroScan in Patients with Cardiac Pacemakers or Implantable Cardioverter-Defibrillators. Canadian Journal of Gastroenterology and Hepatology No. 2017 (2017), pp.1-6.
https://search.emarefa.net/detail/BIM-1141461
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
Chan, Yin& Pranke, Stephanie& Rashidi, Farid& Nosib, Shravan& Worobetz, Lawrence. Safety Profile of Liver FibroScan in Patients with Cardiac Pacemakers or Implantable Cardioverter-Defibrillators. Canadian Journal of Gastroenterology and Hepatology. 2017. Vol. 2017, no. 2017, pp.1-6.
https://search.emarefa.net/detail/BIM-1141461
نوع البيانات
مقالات
لغة النص
الإنجليزية
الملاحظات
Includes bibliographical references
رقم السجل
BIM-1141461
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
![](/images/ebook-kashef.png)
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر
![](/images/kashef-image.png)